Home > Financial Ratios > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.4810.8513.9019.8526.93

What is the latest EV/Core EBITDA ratio of BIOCON ?

The latest EV/Core EBITDA ratio of BIOCON is 12.48 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.48
Mar202410.85
Mar202313.90
Mar202219.85
Mar202126.93

How is EV/Core EBITDA of BIOCON Trending?

Years EV/Core EBITDA % Change
Mar2025 12.48
15.02
Mar2024 10.85
-21.94
Mar2023 13.9
-29.97
Mar2022 19.85
-26.29
Mar2021 26.93 -

Other Financial Ratios of BIOCON


Compare EV/Core EBITDA ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹45,905.9 Cr -4.8% -2.3% 7.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,702.0 Cr -1.9% -4.1% -6.6% Stock Analytics
DIVIS LABORATORIES ₹156,908.0 Cr -3.6% -12.3% 27.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,896.0 Cr -2.1% 7.2% 9.3% Stock Analytics
CIPLA ₹119,988.0 Cr -0.7% -0% -2.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,122.0 Cr -1.6% -5.4% -12.1% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-4.8%

-2.3%

7.8%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses